Using Ozempic to slash those extra pounds? WHO backs weight loss drugs for obesity
The World Health Organization (WHO) now supports the use of GLP-1 drugs like semaglutide (Ozempic, Wegovy) for long-term obesity treatment in adults with a BMI of 30 or higher, alongside lifestyle changes. This shift recognizes obesity as a chronic disease requiring medical intervention, not just a lifestyle choice.
The World Health Organization (WHO) now supports the use of GLP-1 drugs like semaglutide (Ozempic, Wegovy) for long-term obesity treatment in adults with a BMI of 30 or higher, alongside lifestyle changes. This shift recognizes obesity as a chronic disease requiring medical intervention, not just a lifestyle choice.
